The Practice of Food Allergy (Virtual Meeting)
This virtual food allergy meeting will allow participants to increase their knowledge and skills related to the prevention, diagnosis, and treatment of food allergic patients, with special focus on non-IgE-mediated food allergy and nutrition, psycho-social and practice management aspects. It will highlight the latest evidence related to food allergies and will include a combination of lectures and interactive panel discussions to prepare participants to provide optimal care to these patients.
This event will be available live via Zoom on October 20, as well as recorded.
Target Audience
- Physicians
- Fellows in Training
- Physician Assistants
- Nurse Practitioners
- Nurses
- Practice Managers
Learning Objectives
Upon completion of this activity, participants should be able to:
- Translate the approved guidelines for food allergy prevention into practice
- Apply evidence-based decision-making to the diagnosis of food allergic patients
- Identify and apply treatment options currently available for patients with food allergies, as well as discuss future treatment alternative
- Implement evidence-based strategies for the management of non-IgE-mediated food allergy
- Implement processes in practice to address the nutritional and psychosocial aspects of food allergy
- Prepare your practice for the implementation of food allergy treatments, including OIT administration and evaluation and the implementation of early peanut introduction
Program
Friday, October 20, 2023
9 a.m. – 5 p.m. CDT
Virtual on Zoom
Download Agenda
Start Time | End Time | Topic | Faculty |
9:00 AM | 9:05 AM | Opening Remarks | Amal H. Assa'ad, MD FAAAAI |
9:05 AM | 9:35 AM | Morning Keynote: History of Food Allergy & Where We Are Today | Sami L. Bahna, MD DrPH FAAAAI |
9:35 AM | 10:35 AM | Prevention Symposium Guidelines on Early Introduction Around the Globe Can We Reduce Peanut Allergy with Early Introduction? Preventing Food Allergy through Breast Milk Nutrition Question & Answer Panel |
Elissa Michele Abrams, MD FRCPC Kirsten P. Perrett, MD PhD Carina Venter, PhD RD Corinne Keet, MD MS PhD (Moderator) |
10:35 AM | 10:45 AM | 10-minute Break |
|
10:45 AM | 11:45 AM | Diagnostic Symposium A Diagnostic Algorithm for Food Allergy Mast Cell and Basophil Activation Tests Oral Food Challenge Safety, Feasibility and Outcomes Question & Answer Panel |
Hugh A. Sampson, MD FAAAAI Alexandra F. Santos, MD PhD J. Andrew Bird, MD FAAAAI Amal H. Assa'ad, MD FAAAAI (Moderator) |
11:45 AM | 12:45 PM | Nutrition & Psycho-Social Aspects of Food Allergy Symposium Impact of Social Determinants of Health on Food Allergy Patients Food Insecurity & Access to Non-allergenic Foods Role of Behavioral Health in Food Allergy Question & Answer Panel |
Princess U. Ogbogu, MD FAAAAI Christopher M. Warren, PhD Linda Herbert, PhD FAAAAI Jodi Shroba, MSN, APRN, CPNP (Moderator) |
12:45 PM | 1:15 PM | Lunch Break |
|
1:15 PM | 1:45 PM | Afternoon Keynote: History of the Consortium of Food Allergy Research (CoFAR) | Stacie M. Jones, MD FAAAAI |
1:45 PM | 2:45 PM | Treatment/Management Symposium Oral Immunotherapy: Practical Steps Role of Microbiome in Food Allergy Use of Biologics in Food Allergy Question & Answer Panel |
Aikaterini Anagnostou, MD MSc PhD FAAAAI Rima A. Rachid, MD FAAAAI Robert A. Wood, MD FAAAAI Brian Vickery, MD FAAAAI (Moderator) |
2:45 PM | 2:55 PM | 10-minute Break |
|
2:55 PM | 3:55 PM | Non-IgE Food Allergy Symposium Management of EoE with Focus on Dietary Therapy Management of Cow's Milk Protein Allergy Management of Food Avoidance & Advancement in FPIES Question & Answer Panel |
Emily C. McGowan, MD PhD FAAAAI Kirsi M. Jarvinen-Seppo, MD PhD FAAAA Marion E. Groetch, MS RDN Benjamin Wright, MD FAAAAI (Moderator) |
3:55 PM | 4:55 PM | Practice Management Symposium Developing SOPs for your Food Allergy Clinic Billing and Template Management Managing the Maintenance Phase of OIT in the Real World Question & Answer Panel |
Christa Mills, MSN RN CNL CPN Sakina S. Bajowala, MD FAAAAI Kim E. Mudd, RN MSN CCRP Christina Ciaccio, MD FAAAAI (Moderator) Megan Ott Lewis, MSN, CRNP (Panelist) |
4:55 PM | 5:00 PM | Closing Remarks | Amal H. Assa'ad, MD FAAAAI |
Planning Committee
Aikaterini Anagnostou, MD MSc PhD FAAAAI
Texas Children's Hospital, Houston, TX
Relevant relationships: ALK (consultant); Aimmune Therapeutics, Novartis (research grant)
Amal H. Assa'ad, MD FAAAAI
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Relevant relationships: Aimmune, Astellas, DBV Technologies, Sanofi, Siolta, Syneos (research grant)
Christina Ciaccio, MD FAAAAI
University of Chicago, Chicago, IL
Relevant relationships: Clostrabio, Siolta (advisory board); ALK, Astra-Zeneca, DBV, Genentech, Novartis, Sanofi-Genzyme (consultant); Aimmune (speaker)
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant relationships: None
Rima A. Rachid, MD FAAAAI
Children's Hospital-Boston, Boston, MA
Relevant relationships: Novartis (advisory board); Up-to-Date (honorarium); Aimmune Therapeutics, Novartis, Siolta (research grant)
Jodi Shroba, MSN APRN CPNP
Children's Mercy Hospital, Kansas City, KS
Relevant relationships: Thermo Fisher (advisory board); Aimmune (speaker)
Benjamin L. Wright, MD FAAAAI
Children's Mercy Hospital, Kansas City, KS
Relevant relationships: None
Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant relationships: Aimmune Therapeutics, AllerGenis, DBV Technologies, Reacta Biosciences, Regeneron (advisory board); Aravax, Moonlight Therapeutics (consultant); Abbott, Aimmune Therapeutics, DBV Technologies, Genentech, Regeneron (research grant)
Faculty
Elissa Michele Abrams, MD FRCPC
University of Manitoba, Winnipeg, MB
Relevant Relationships: None
Aikaterini Anagnostou, MD MSc PhD FAAAAI
Texas Children's Hospital, Houston, TX
Relevant Relationships: Aimmune, Novartis (research grant)
Amal H. Assa'ad, MD FAAAAI
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Relevant Relationships: Aimmune, DBV Technologies, Sanofi, Siolta, Syneos (research grant)
Sami L. Bahna, MD DrPH FAAAAI
LA State University Health Sciences Center, Shreveport, LA
Relevant Relationships: None
Sakina S. Bajowala, MD FAAAAI
Wise Prince LLC, North Aurora, IL
Relevant Relationships: None
J. Andrew Bird, MD FAAAAI
UT Southwestern Medical Center, Dallas, TX
Relevant Relationships: AllerGenis, Allergy Therapeutics, DBV Technologies, Genentech, Novartis (advisory board); HAL-Allergy, Nutricia (consultant); Aimmune Therapeutics, Astellas, DBV Technologies, Genentech, Novartis, Regeneron, Siolta (research grant); DBV Technologies (speaker)
Christina Ciaccio, MD FAAAAI
University of Chicago, Chicago, IL
Relevant Relationships: Clostrabio, Siolta (advisory board); Astra-Zeneca, Genentech, Novartis, Sanofi-Genzyme (consultant)
Marion E. Groetch, MS RDN
Icahn School of Medicine at Mount Sinai, New York, NY
Relevant Relationships: None
Linda Herbert, PhD FAAAAI
Children's National Health System, Washington, DC
Relevant Relationships: None
Kirsi M. Jarvinen-Seppo, MD PhD FAAAAI
University of Rochester Medical Center, Rochester, MN
Relevant Relationships: None
Stacie M. Jones, MD FAAAAI
UAMS/Arkansas Children's Hospital, Little Rock, AR
Relevant Relationships: None
Corinne Keet, MD MS PhD
University of North Carolina, Chapel Hill, NC
Relevant Relationships: None
Megan Ott Lewis, MSN, CRNP
Children's Hospital of Philadelphia, Philadelphia, PA
Relevant Relationships: None
Emily C. McGowan, MD PhD FAAAAI
University of Virginia School of Medicine, Charlottesville, VA
Relevant Relationships: None
Christa Mills, MSN RN CNL CPN
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Relevant Relationships: None
Kim E. Mudd, RN MSN CCRP
Johns Hopkins University, Baltimore, MD
Relevant Relationships: None
Princess U. Ogbogu, MD FAAAAI
University Hospitals Rainbow Babies and Children's Hospital, Cleveland, OH
Relevant Relationships: None
Kirsten P. Perrett, MD PhD
Murdoch Children's Research Institute, Parkville, AU
Relevant Relationships: Aravax (consultant); Aravax, DBV Technologies, Novartis, Siolta (research grant)
Rima A. Rachid, MD FAAAAI
Children's Hospital-Boston, Boston, MA
Relevant Relationships: Novartis (advisory board); Up-to-Date (honorarium); Aimmune Therapeutics, Novartis, Siolta (research grant)
Hugh A. Sampson, MD FAAAAI
Icahn School of Medicine at Mount Sinai, New York, NY
Relevant Relationships: None
Alexandra F. Santos, MD PhD
King's College London, London, UK
Relevant Relationships: None
Jodi Shroba, MSN, APRN, CPNP
Children's Mercy Hospital, Kansas City, KS
Relevant Relationships: Thermo Fisher (advisory board)
Carina Venter, PhD RD
Children's Hospital Colorado, Aurora, IL
Relevant Relationships: Abbott Laboratories, Danone, Danone, Nestle, Reckitt, HAL Allergy (speaker); Bobbie (consultant)
Brian Vickery, MD FAAAAI
Emory University, Atlanta, GA
Relevant Relationships: Aimmune Therapeutics, AllerGenis, DBV Technologies, Reacta Biosciences, Regeneron, Novartis (advisory board); Aravax, Moonlight Therapeutics, Sanofi, Stallergenes Greer (consultant); Abbott, Aimmune Therapeutics, DBV Technologies, Genentech, Regeneron, (research grant); Moonlight Therapeutics (stocks)
Christopher M. Warren, PhD
Northwestern University Center for Food Allergy and Asthma Research, Chicago, IL
Relevant Relationships: None
Robert A. Wood, MD FAAAAI
Johns Hopkins University School Medicine, Baltimore, MD
Relevant Relationships: Aimmune, ALK, DBV Technologies, Genentech, Novartis, Siolta (research grant)
Benjamin Wright, MD FAAAAI
Mayo Clinic Arizona, Scottsdale, AZ
Relevant Relationships: None
Content Reviewers
Kevin Parks, MD FAAAAI
AAC/CRI of Southern Oregon, Medford, OR
Relevant relationships: None
The information disclosed by the speakers and planning committee was reviewed in accordance with the AAAAI Disclosure Policy. All potential conflicts of interest were resolved by the planners, faculty, and reviewers prior to their participation in the development of this activity.
AAAAI Disclosure Policy
Pursuant to the Code of Ethics for the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Standards for Commercial Support of Continuing Medical Education of the Accreditation Council for Continuing Medical Education, the AAAAI requires disclosure of certain information from faculty members of educational activities designated for CME credit by the AAAAI. Prior to the activity, authors and reviewers are required to disclose all relationships that meet the following parameters:
- Employment: Name of employer and job title.
- Financial interests: All organizations, other than the employer, from which the faculty member or a member of his/her immediate family or household receives annual remuneration in any amount (including grants, honoraria and consulting fees).
- Research interests: All organizations which support research projects for which the faculty member or member of his/her immediate family or household serves as an investigator.
- Legal Consultation Services/Expert Witness Testimony: All topics on which the faculty member provided legal consultation and/or expert witness testimony during the previous calendar year.
- Organizational interests: All organizations, other than the AAAAI, for which the faculty member holds volunteer positions.
- Gifts: All organizations from which the faculty member or a member of his/her immediate family or household have received a gift of any amount in the last year.
- Other interests: All interests of the faculty member or a member of his/her immediate family or household that would be judged by a majority of his/her peers to be more than casual and/or likely to impact his/her ability to exercise independent judgment. This includes any financial interest in or relationship with any manufacturer of a commercial product, and any financial interest or relationship with any organization that provides commercial support to AAAAI-sponsored educational activities.
Accreditation Statement
The American Academy of Allergy, Asthma and Immunology (AAAAI) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Designation Statement
The American Academy of Allergy, Asthma & Immunology designates this other activity (live meeting & recording) for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE Designation Statement
The American Academy of Allergy, Asthma, & Immunology (AAAAI) is a Provider, approved by the California Board of Registered Nursing, Provider #10704, for up to 6.00 Contact Hours.
Credit Claiming Period
Credit claiming for this activity will expire at 11:59 pm on October 31, 2024. Requests to claim credit on or after November 1, 2024 will be subject to an administrative fee.
Medium and Method of Physician Participation for a Live Activity
Follow these steps to complete the activity:
1. Register for the activity.
2. Review the CME and Disclosure information.
3. Attend the meeting. Be sure to 'sign in' so your attendance can be recorded.
4. Return to the online meeting site after the meeting and complete the activity evaluation.
5. Claim your credits. Enter only the number of credits earned based on your participation in the activity.
6. Print or save your certificate.
Questions
Credit claiming questions should be directed to cme@aaaai.org.
Available Credit
- 6.00 AttendanceAttendance credit.
- 6.00 CECE credit.
- 6.00 CMECME credit.
Price
By registering for this educational activity you are confirming that you have read the Privacy and Data Protection Notice and agree to the terms as outlined below:
Privacy and Data Protection Notice
The American Academy of Allergy, Asthma & Immunology (AAAAI) takes your privacy seriously. AAAAI will only use your personal information to administer your registration, attendance, and credit claiming/attendance record for this activity, to provide services that you have requested from AAAAI and otherwise as you may expressly consent. A complete copy of AAAAI’s Legal and Privacy Notices, the terms of which are incorporated herein, can be found here.
By providing consent, you are allowing AAAAI to process your personal data. AAAAI will collect and store information you provide in the Registration/Housing Forms for the purposes of enabling us to register your attendance at the activity; to assist with administrative, planning and marketing purposes; and to allow the compilation and analysis of statistics relevant to AAAAI.
The information you provide in the Registration/Housing Forms, and information provided at any other time during this activity, including without limitation any feedback obtained during the activity, will be used by AAAAI to offer, provide and continue to improve its educational activities and other services. The AAAAI will also use your email address to communicate important information regarding this activity and for marketing purposes for future activities. AAAAI will not otherwise, without your consent, use or disclose your personal information for any purpose unless it would reasonably be expected that such a purpose is related to the offer, provision and improvement of the activity or where such purpose is permitted or required by law.
For courses/events with industry support and/or exhibitors, The AAAAI may disclose some information that is collected in the Registration Form such as your name, credentials, title/position, organization, and mailing address to exhibitors and industry supporters for marketing purposes such as to receive mailed literature. In addition to, but separate from, your consent regarding being contacted by exhibitors and industry supporters with mailed literature, when you visit sponsored areas within the virtual platform for an online event (such as, but not limited to, an exhibitor’s virtual exhibit booth), that organization will receive your personal contact information (name, credentials, title/position, organization, mailing address, phone number, email address and NPI number, if applicable). If you do not want to share your personal contact information with any/all of those organizations, please do not visit those areas within our virtual platform. By accessing any/all of those areas in our virtual platform, you are consenting to share your personal contact information with all organizations whose sponsored areas you visit in our virtual platform. If you attend this activity in person, and provide your contact information to an exhibitor or industry supporter (including allowing them to scan your name badge), you are consenting to share your personal contact information with that organization. You have the right to decline an exhibitor and/or industry supporter’s request for your personal contact information. AAAAI does not control the use or distribution of personal contact information transferred when you visit a sponsored area in the virtual platform or, if in person, when you share your personal contact information, and as such, AAAAI shall not be held responsible for any misuse of your personal data obtained by exhibitors or industry supporters in this manner. You have the right to ask the exhibitor or industry supporter questions about how they will use your personal data, how long it will be retained and if they will share information with third parties.
After you have submitted your personal contact information in the registration form, you may change your preferences for receiving emails by following the instructions below:
· To change your preferences for receiving emails from AAAAI regarding future annual meetings and/or other in-person and online education programs, please visit http://aaaai.execinc.com/edibo/Profile
· For events where industry support or exhibitions are involved please email cme@aaaai.org to change your consent to be contacted by the industry supporters and exhibitors of that activity.
NOTE: AAAAI may be photographing this activity. These photographs, along with your name, may be used in AAAAI publications or on the AAAAI website. If you do not want your photo used, please inform the staff photographer at the time the photograph is taken. AAAAI may also be audio recording education sessions during this activity. If you verbally submit any questions for Question & Answer sessions (Q&A), you are agreeing to be recorded and to have that recording available in enduring materials. If you prefer not to be audio recorded, please submit any questions you have in writing.
I understand that it is my right to withhold consent to the above Privacy and Data Protection Notice, or to withdraw my previous consent at any time. I further understand that without my consent, it is not possible to process my registration/housing request for this activity. Please contact the AAAAI Education Team at (414) 272-6071 if you have any further questions about how this will affect your registration/housing request for this activity.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari.
Internet Explorer is no longer supported.